HIV medication subject to tenders

The Norwegian parliament has decided that medicines supplied through the hospitals shall be subject to a tender in order to reduce costs. This also applies to drugs for treating HIV infection. Hospitals are obliged to prescribe those medicines that won the tender.

scheduleOppdatert: 14.02.2023

createForfatter: sekretariatet

labelEmner:

In November 2022 results from the third round of tenders were announced. This time HivNorway is pleased with the outcome. Two significant positive outcomes from this round of tenders is that the medications on the list are all combination tablets, or single tablets. Secondly, there is equal recommendations from the national guidelines for hiv treatment and the outcome of the medication subject to tenders. This time it is also more clearly spesified that any medical reasons why a person should be prescribed medication different from what is on the list, can be justified in the patients records. It is therefore important that you have a close and open dialogue with your medical doctor so you can receive the most appropriate medication taking into consideration guidelines, cost, overall health and wellbeing.

These are the combinations that won the tender in 2022:

  1. Delstrigo (doravirin/lamivudine/tenofovir disproksil)
  2. Dovato (dolutegravir/lamivudine)
  3. Triumeq (dolutegravir/abacavir/lamivudine)
  4. Biktarvy (biktegravir/emtricitabine/TAF)

Genvoya, a medication commonly used, shall be changed to other medications as it is no longer among the recommended tablets.

If you have any other questions or need assistance, please do not hesitate to contact us. You can reach us by phone 21314580, via Messenger, on our Facebook page (HivNorge) or via email.

Les også

schedule27.06.2025

→ Skeives helse – et globalt anliggende? 

Retten til helse er en grunnleggende menneskerettighet som skal gjelde for alle, uansett bakgrunn. Det er imidlertid et stort spørsmål om hvor tilgjengelig helsehjelpen man har rett på er for utsatte grupper i våre samfunn.

schedule25.06.2025

→ Norge gir 10 milliarder kroner til global helse

Norge gir 10 milliarder kroner til vaksinealliansen Gavi og Det globale fondet for bekjempelse av aids, tuberkulose og malaria, skriver regjeringen i en pressemelding. Norge er dermed det første landet til å annonsere sin støtte til Det globale fondet for perioden 2026-2028.